Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

NCT00148135 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped recruitment goals met

Conditions

Carcinoma of Unknown Primary

Interventions

DRUG: Carboplatin
DRUG: Gemcitabine
DRUG: Capecitabine

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]